Skip to main content
Log in

Error analysis in newborn screening: can quotients support the absolute values?

  • Rapid Communication
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

Newborn screening is performed using modern tandem mass spectrometry, which can simultaneously detect a variety of analytes, including several amino acids and fatty acids. Tandem mass spectrometry measures the diagnostic parameters as absolute concentrations and produces fragments which are used as markers of specific substances. Several prominent quotients can also be derived, which are quotients of two absolute measured concentrations. In this study, we determined the precision of both the absolute concentrations and the derived quotients. First, the measurement error of the absolute concentrations and the measurement error of the ratios were practically determined. Then, the Gaussian theory of error calculation was used. Finally, these errors were compared with one another. The practical analytical accuracies of the quotients were significantly higher (e.g., coefficient of variation (CV) = 5.1% for the phenylalanine to tyrosine (Phe/Tyr) quotient and CV = 5.6% for the Fisher quotient) than the accuracies of the absolute measured concentrations (mean CVs = 12%). According to our results, the ratios are analytically correct and, from an analytical point of view, can support the absolute values in finding the correct diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

Abbreviations

ALA:

Alanine

ARG:

Arginine

ASA:

Argininosuccinic acid

C0:

Free carnitine

C10:

Decanoylcarnitine

C10:1:

Decenoylcarnitine

C12:

Dodecanoylcarnitine

C14:

Myristoylcarnitine

C14:1:

Myristoleylcarnitine (tetradecanoyl-)

C14:2:

Tetradecadienoylcarnitine

C16:

Palmitoylcarnitine (hexadecanoyl-)

C16OH:

3-Hydroxy-palmitoylcarnitine

C18:

Stearoylcarnitine (octadecanoyl-)

C18:1:

Octadecenoylcarnitine

C18:1OH:

3-Hydroxy-octadecenoylcarnitine

C18OH:

3-Hydroxy-stearoylcarnitine

C2:

Acetylcarnitine

C3:

Propionylcarnitine

C3DC:

Malonylcarnitine

C4:

Butanoylcarnitine

C4DC:

Methylmalonylcarnitine

C5:

Isovalerylcarnitine

C5:1:

Tiglylcarnitine

C5DC:

Glutarylcarnitine

C5OH:

Hydroxyisovalerylcarnitine

C6:

Hexanoylcarnitine

C8:

Octanoylcarnitine

CIT:

Citrulline

GLY:

Glycine

LEU:

Leucine/Isoleucine

MET:

Methionine

ORN:

Ornithine

PHE:

Phenylalanine

TYR:

Tyrosine

VAL:

Valine

References

  1. Shewhart WA. Economic control of quality of manufactured product. New York: Van Nostrand; 1931.

    Google Scholar 

  2. Levey S, Jennings ER. The use of control charts in the clinical laboratory. Am J Clin Pathol. 1950;20(11):1059–66.

    CAS  Google Scholar 

  3. Westgard JO, Barry PL, Hunt MR. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem. 1981;27(3):493–501.

    CAS  Google Scholar 

  4. Westgard JO, Groth T, Aronsson T, Falk H, de Verdier CH. Performance characteristics of rules for internal quality control: probabilities for false rejection and error detection. Clin Chem. 1977;23:1857–67.

    CAS  Google Scholar 

  5. Westgard JO, Groth T. Power functions for statistical control rules. Clin Chem. 1979;25(6):863–9.

    CAS  Google Scholar 

  6. Westgard JO, Groth T, Aronason T, de Verdier CH. Combined Shewhart-Cusum control chart for improved quality control in clinical chemistry. Clin Chem. 1977;23(10):1881–7.

    CAS  Google Scholar 

  7. Blum AS. Computer evaluation of statistical procedures, and a new quality control statistic procedure. Clin Chem. 1985;31(2):206–12.

    CAS  Google Scholar 

  8. Yunus ZM, Rahman SA, Choy YS, Keng WT, Ngu LH. Pilot study of newborn screening of inborn errors of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges. J Pediatr Endocrinol Metab. 2016;29(9):1031–9.

    Article  CAS  Google Scholar 

  9. Yoon HR. Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry. Ann Pediatr Endocrinol Metab. 2015;20(4):238.

    Article  Google Scholar 

  10. Scolamiero E, Cozzolino C, Albano L, Ansalone A, Caterino M, Corbo G, et al. Targeted metabolomics in the extended newborn screening for inborn errors of metabolism. Mol BioSyst. 2015;11(6):1525–35.

    Article  CAS  Google Scholar 

  11. Sabbagh B, Mindt S, Neumaier M, Findeisen P. Clinical applications of MS-based protein quantification. Proteomics Clin Appl. 2016;10(4):323–45.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Borros Arneth.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arneth, B., Hintz, M. Error analysis in newborn screening: can quotients support the absolute values?. Anal Bioanal Chem 409, 2247–2253 (2017). https://doi.org/10.1007/s00216-017-0179-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-017-0179-z

Keywords

Profiles

  1. Borros Arneth